No other clinically meaningful difference was apparent between venlafaxine and placebo in the benign safety profile, including laboratory measurements and vital signs.
← all excerpts
A randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of venlafaxine extended release and a long-term extension study for patients with major depressive disorder in Japan.
1
—
—